down side of semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products Semaglutide and Tirzepatide Side Effects
Description
Wegovy 7.2 mg is already approved for adults with obesity in the EU and the UK
Mallik R, Chowdhury TA
Writing in The Lancet Psychiatry, the authors said GLP-1 receptor agonists semaglutide and liraglutide, sold under the brand name Saxenda, were associated with lower risk of worsening mental illness compared to non-use of this type of drug
Anorexia has the highest mortality rate of any psychiatric disorder
